Five weeks after winning U.S. FDA approval of Emcitate (tiratricol) to treat peripheral thyrotoxicosis in those with MCT8 ...

T-Therapeutics Ltd. has raised $133 million in an oversubscribed series B, providing the means to deliver clinical proof of concept for its T-cell receptor-CD3 bispecifics in solid tumors and ...

Abbvie Inc. is paying Nxera Pharma Co. Ltd. $100 million up front for worldwide rights to NXE-0033744, a phase II-ready oral EP4 receptor agonist designed to act locally in the gastrointestinal tract ...

Alethio Therapeutics Ltd. has closed a £67 million (US$90.3 million) series A round that with a fair wind will see its lead ...

A pair of popular modalities stands at the back-end-loaded, potential $7 billion-plus deal inked by Boehringer Ingelheim GmbH ...

For only the fourth time since World War II, the U.S. midterm election flipped control of both the House and the Senate. (The ...

China’s clinical trial advantage is beginning to reshape more than the development of Chinese drugs. Faster recruitment, lower costs and growing scientific capabilities are raising a broader question: ...

Med-tech financings across all categories totaled $3.29 billion in the third quarter (Q3) of 2026, down 14.5% from $3.86 billion in Q2 and 61% from $8.54 billion in Q1, marking the lowest quarterly ...

The publication this spring in The Lancet Respiratory Medicine of new data with Amgen Inc. and Astrazeneca plc’s Tezspire (tezepelumab) fed hopes in severe asthma, where a handful of developers are ...

Medtronic plc revealed new data which showed that its Symplicity Spyral renal denervation (RDN) system significantly reduced blood pressure (BP) in a diverse patient population. Office systolic BP ...

Colorectal cancer (CRC) remains difficult to treat, particularly after resistance to targeted therapies and immunotherapy ...

Researchers are taking new steps to improve CAR T-cell therapies by better understanding their behavior and engineering them to overcome some of their limitations, from treatment failure and T-cell ...